Literature DB >> 23403179

NAD+ and nicotinamide: sex differences in cerebral ischemia.

C S Siegel1, L D McCullough.   

Abstract

BACKGROUND: Previous literature suggests that cell death pathways activated after cerebral ischemia differ between the sexes. While caspase-dependent mechanisms predominate in the female brain, caspase-independent cell death induced by the activation of poly(ADP-ribose) polymerase (PARP) predominates in the male brain. PARP-1 gene deletion decreases infarction volume in the male brain, but paradoxically increases damage in PARP-1 knockout females.
PURPOSE: This study examined stroke-induced changes in NAD+, a key energy molecule involved in PARP-1 activation in both sexes.
METHODS: Mice were subjected to middle cerebral artery occlusion and NAD+ levels were assessed. Caspase-3 activity and nuclear translocation were assessed 6h after ischemia. In additional cohorts, Nicotinamide (500 mg/kg i.p.) a precursor of NAD+ or vehicle was administered and infarction volume was measured 24h after ischemia.
RESULTS: Males have higher baseline NAD+ levels than females. Significant stroke-induced NAD+ depletion occurred in males and ovariectomized females but not in intact females. PARP-1 deletion prevented the stroke-induced loss in NAD+ in males, but worsened NAD+ loss in PARP-1 deficient females. Preventing NAD+ loss with nicotinamide reduced infarct in wild-type males and PARP-1 knockout mice of both sexes, with no effect in WT females. Caspase-3 activity was significantly increased in PARP-1 knockout females compared to males and wild-type females, this was reversed with nicotinamide.
CONCLUSIONS: Sex differences exist in baseline and stroke-induced NAD+ levels. Nicotinamide protected males and PARP knockout mice, but had minimal effects in the wild-type female brain. This may be secondary to differences in energy metabolism between the sexes.
Copyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23403179      PMCID: PMC3609901          DOI: 10.1016/j.neuroscience.2013.01.068

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  46 in total

Review 1.  Estrogen and stroke: a balanced analysis.

Authors:  Patricia D Hurn; Lawrence M Brass
Journal:  Stroke       Date:  2003-02       Impact factor: 7.914

Review 2.  Mitochondrial contributions to tissue damage in stroke.

Authors:  Neil R Sims; Michelle F Anderson
Journal:  Neurochem Int       Date:  2002-05       Impact factor: 3.921

3.  Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.

Authors:  S Imai; C M Armstrong; M Kaeberlein; L Guarente
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

Review 4.  Poly(ADP-ribose) polymerase: killer or conspirator? The 'suicide hypothesis' revisited.

Authors:  Alberto Chiarugi
Journal:  Trends Pharmacol Sci       Date:  2002-03       Impact factor: 14.819

5.  Nicotinamide attenuates focal ischemic brain injury in rats: with special reference to changes in nicotinamide and NAD+ levels in ischemic core and penumbra.

Authors:  Fumiko Sadanaga-Akiyoshi; Hiroshi Yao; Sei-ichi Tanuma; Tatsuo Nakahara; Jong Soon Hong; Setsuro Ibayashi; Hideyuki Uchimura; Masatoshi Fujishima
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

Review 6.  Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra.

Authors:  Isidro Ferrer; Anna María Planas
Journal:  J Neuropathol Exp Neurol       Date:  2003-04       Impact factor: 3.685

7.  Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection.

Authors:  Louise D McCullough; Kathleen Blizzard; Evan R Simpson; Orhan K Oz; Patricia D Hurn
Journal:  J Neurosci       Date:  2003-09-24       Impact factor: 6.167

8.  Identification of the primary caspase 3 cleavage site in alpha II-spectrin during apoptosis.

Authors:  S T Williams; A N Smith; C D Cianci; J S Morrow; T L Brown
Journal:  Apoptosis       Date:  2003-08       Impact factor: 4.677

9.  NAD+ repletion prevents PARP-1-induced glycolytic blockade and cell death in cultured mouse astrocytes.

Authors:  Weihai Ying; Philippe Garnier; Raymond A Swanson
Journal:  Biochem Biophys Res Commun       Date:  2003-09-05       Impact factor: 3.575

10.  The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity.

Authors:  Carles Cantó; Riekelt H Houtkooper; Eija Pirinen; Dou Y Youn; Maaike H Oosterveer; Yana Cen; Pablo J Fernandez-Marcos; Hiroyasu Yamamoto; Pénélope A Andreux; Philippe Cettour-Rose; Karl Gademann; Chris Rinsch; Kristina Schoonjans; Anthony A Sauve; Johan Auwerx
Journal:  Cell Metab       Date:  2012-06-06       Impact factor: 27.287

View more
  24 in total

1.  Nicotinamide mononucleotide alters mitochondrial dynamics by SIRT3-dependent mechanism in male mice.

Authors:  Nina Klimova; Aaron Long; Tibor Kristian
Journal:  J Neurosci Res       Date:  2019-02-23       Impact factor: 4.164

Review 2.  Mitochondrial maintenance failure in aging and role of sexual dimorphism.

Authors:  John Tower
Journal:  Arch Biochem Biophys       Date:  2014-10-25       Impact factor: 4.013

Review 3.  Sex differences in neuroinflammation and neuroprotection in ischemic stroke.

Authors:  Monica S Spychala; Pedram Honarpisheh; Louise D McCullough
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 4.  Cutting through the complexities of mTOR for the treatment of stroke.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2014-05       Impact factor: 1.990

Review 5.  Sex differences in mitochondrial (dys)function: Implications for neuroprotection.

Authors:  Tyler G Demarest; Margaret M McCarthy
Journal:  J Bioenerg Biomembr       Date:  2014-10-08       Impact factor: 2.945

6.  Sex-dependent mitophagy and neuronal death following rat neonatal hypoxia-ischemia.

Authors:  T G Demarest; E L Waite; T Kristian; A C Puche; J Waddell; M C McKenna; G Fiskum
Journal:  Neuroscience       Date:  2016-08-21       Impact factor: 3.590

7.  The effects of nicotinamide on reinstatement to cocaine seeking in male and female Sprague Dawley rats.

Authors:  Emily A Witt; Kathryn J Reissner
Journal:  Psychopharmacology (Berl)       Date:  2019-12-07       Impact factor: 4.530

Review 8.  Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury.

Authors:  Katrina Owens; Ji H Park; Rosemary Schuh; Tibor Kristian
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

9.  Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia.

Authors:  Ji H Park; Aaron Long; Katrina Owens; Tibor Kristian
Journal:  Neurobiol Dis       Date:  2016-07-15       Impact factor: 5.996

10.  Raloxifene and Tamoxifen Reduce PARP Activity, Cytokine and Oxidative Stress Levels in the Brain and Blood of Ovariectomized Rats.

Authors:  Betül Yazğan; Yener Yazğan; İshak Suat Övey; Mustafa Nazıroğlu
Journal:  J Mol Neurosci       Date:  2016-07-02       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.